Disperazol Pharma, a leading biotechnology firm that develops compounds that dismantle biofilms of critical Gram—negative pathogens, today announced that it has joined the AMR Industry Alliance. AMR is currently responsible for an estimated 1.27 million deaths annually worldwide, with projections warning of even greater impacts if action is delayed.